MELBOURNE, Australia, Nov. 3 /PRNewswire-FirstCall/ -- Prana Biotechnology Limited , today announced that Geoffrey Kempler, Executive Chairman and Chief Executive Officer, will present at the Rodman & Renshaw Techvest Seventh Annual Healthcare Conference at 3:50 p.m. Eastern Time on Tuesday, November 8 (07.50 a.m. Melbourne Time on Wednesday, November 9) at The New York Palace Hotel. During the presentation, Mr. Kempler will address the current status of Prana’s development program.
The Company’s audio and slide presentation will be web cast live on November 8. A replay will be available one hour following the presentation and archived on the Company’s web site for 90 days. To access the live and replay presentations, visit the Prana Biotechnology web site, http://www.pranabio.com.
About Prana Biotechnology Limited
Prana Biotechnology was established to commercialize research into Alzheimer’s disease and other major age-related degenerative disorders. The company was incorporated in 1997 and listed on the Australian Stock Exchange in March 2000 and listed on NASDAQ in September 2002. Researchers at prominent international institutions including the University of Melbourne and Massachusetts General Hospital, a teaching hospital of Harvard Medical School, discovered Prana’s technology.
For further information, please visit our web site at http://www.pranabio.com. Contacts: Investor Relations Media Relations Kathy Price Ivette Almeida The Global Consulting Group The Global Consulting Group T: 646-284-9430 T: 646-284-9455 E: kprice@hfgcg.com E: ialmeida@hfgcg.com
Prana Biotechnology Limited
CONTACT: Investor Relations - Kathy Price, +1-646-284-9430,kprice@hfgcg.com, Media Relations - Ivette Almeida, +1-646-284-9455,ialmeida@hfgcg.com, both of The Global Consulting Group for PranaBiotechnology Limited
Web site: http://www.pranabio.com/
